Cell-cycle-dependent PC-PLC regulation by APC/CCdc20-mediated ubiquitin-proteasome pathway

Journal of Cellular Biochemistry

Volumn 107, Issue 4, 2009, Pages 686-696

  Fu, Da ^a   Ma, Yushui ^b   Wu, Wei ^a   Zhu, Xuchao ^a   Jia, Chengyou ^a   Zhao, Qianlei ^a   Zhang, Chunyi ^a   Xing, Zhong Wu ^a  

^a FUDAN UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

Author keywords

APC C; Cdc20; Cell Cycle; PC PLC; UPP

Indexed keywords

ANAPHASE PROMOTING COMPLEX; CELL CYCLE PROTEIN 20; PHOSPHATIDYLCHOLINE SPECIFIC PHOSPHOLIPASE C; PHOSPHOLIPASE C; PROTEASOME; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE PHASE; CELL CYCLE REGULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT; UBIQUITINATION;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; ENDOPLASMIC RETICULUM; LIVER; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; TYPE C PHOSPHOLIPASES; UBIQUITIN;

RATTUS;

EID: 67650084414     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22163     Document Type: Article

References (52)

1. Arvand A, Bastians H, Welford SM, Thompson AD, Ruderman JV, Denny CT. 1998. EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene 17:2039-2045. (Pubitemid 28499330)
2. Bastians H, Townsley FM, Ruderman JV. 1998. The cyclin-dependent kinase inhibitor p27 (Kip1) induces N-terminal proteolytic cleavage of cyclin A. Proc Natl Acad Sci USA 95:15374-15381. (Pubitemid 29018706)
3. Bharadwaj R, Yu H. 2004. The spindle checkpoint, aneuploidy, and cancer. Oncogene 23:2016-2027.
4. Camasses A, Bogdanova A, Shevchenko A, Zachariae W. 2003. The CCT chaperonin promotes activation of the anaphase promoting complex through the generation of functional Cdc20. Mol Cell 12:87-100. (Pubitemid 36945038)
5. Cecchetti S, Spadaro F, Lugini L, Podo F, Ramoni C. 2007. Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells. Eur J Immunol 37:2912-2922. (Pubitemid 47578310)
6. Chen HL, Wu XZ, Tong H, Qureshi IA. 1997. Correlation between the dynamic changes of lipids and phospholipases during induced hepatocarcinogenesis. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 29:489-494.
7. 0 alpha-subunit results in a transformed phenotype and constitutively active phosphatidylcholine- specific phospholipase C. J Biol Chem 272:17312-17319.
8. Chung T, Crilly KS, Anderson WH, Mukherjee JJ, Kiss Z. 1997. ATP-dependent choline phosphate-induced mitogenesis in fibroblasts involves activation of pp70 S6 kinase and phosphatidylinositol 3′-kinase through an extracellular site. Synergistic mitogenic effects of choline phosphate and sphingosine 1-phosphate. J Biol Chem 272:3064-3072. (Pubitemid 27053362)
9. Clark MA, Shorr RGL, Bomalaski JS. 1986. Antibodies prepared to Bacillus cereus phospholipase C crossreact with a phosphatidylcholine preferring phospholipase C in mammalian cells. Biochem Biophys Res Commun 140:114-119.
10. Diaz-Laviada I, Larrodera P, Diaz-Meco MT, Cornet ME, Guddal PH, Johansen T, Moscat J. 1990. Evidence for a role of phosphatidylcholine-hydrolysing phospholipase C in the regulation of protein kinase C by ras and src oncogenes. EMBO J 9:3907-3912. (Pubitemid 20379981)
11. 1 in the developing Drosophila eye: rca1 regulates cyclin A. Genes Dev 11:94-105.
12. Exton JH. 1990. Signaling through phosphatidylcholine breakdown. J Biol Chem 265:1-4.
13. Eytan E, Moshe Y, Braunstein I, Hershko A. 2006. Roles of the anaphase-promoting complex/cyclosome and of its activator Cdc20 in functional substrate binding. Proc Natl Acad Sci USA 103:2081-2086. (Pubitemid 43271626)
14. Fang G, Yu H, Kirschner MW. 1998. Direct binding of Cdc20 protein family members activate the anaphase-complex in mitosis and G1. Mol Cell 2:163-171. (Pubitemid 128373642)
15. Fry AM, Yamano H. 2006. APC/C-mediated degradation in early mitosis. How to avoid spindle assembly checkpoint inhibition. Cell Cycle 5:1487-1491.
16. Hoyt MA. 2001. A new view of the spindle checkpoint. J Cell Biol 154:909-911.
17. Hu P, Shi BZ, Geng F, Zhang CY, Wu W, Wu XZ. 2008. E-cadherin core fucosylation regulates nuclear β-catenin accumulation in lung cancer cells. Glycoconj J 25:843-850.
18. Johansen T, Bjorkoy G, Overvatn A, Diaz-Meco MT, Traavik T, Moscat J. 1994. NIH 3T3 cells stably transfected with the gene encoding phosphatidylcholine-hydrolyzing phospholipase C from Bacillus cereus acquire a transformed phenotype. Mol Cell Biol 14:646-654. (Pubitemid 2025586)
19. Kaganovich D, Kopito R, Frydman J. 2008. Misfolded proteins partition between two distinct quality control compartments. Nature 454:1088-1095.
20. Kraft C, Herzog F, Gieffers C, Mechtler K, Hagting A, Pines J, Peters JM. 2003. Mitotic regulation of the human anaphase-promoting complex by phosphorylation. EMBO J 22:6598-6609. (Pubitemid 38009606)
21. Kraft C, Vodermaier HC, Maurer-Stroh S, Eisenhaber F, Peters JM. 2005. The WD40 propeller domain of Cdh1 functions as a destruction box receptor for APC/C substrates. Mol Cell 18:543-553. (Pubitemid 40726231)
22. Li F, Wu N, Su R, Zheng J, Xu B, Lu X, Cong B, Li J. 2006. Involvement of phosphatidylcholine-selective phospholipase C in activation of mitogen-activated protein kinase pathways in imidazoline receptor antisera-selected protein. J Cell Biochem 98:1615-1628. (Pubitemid 44141864)
23. Lin CC, Hsiao LD, Chien CS, Lee CW, Hsieh JT, Yang CM. 2004. Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression in human tracheal smooth muscle cells: Involvement of p42/p44 and p38 mitogen-activated protein kinases and NF-κB. Cell Signal 16:597-607. (Pubitemid 38125146)
24. Lindon C. 2008. Control of mitotic exit and cytokinesis by the APC/C. Biochem Soc Trans 36:405-410. (Pubitemid 351839343)
25. Monick MM, Carter AB, Gudmundsson G, Mallampalli R, Powers LS, Hunninghake GW. 1999. A phosphatidylcholine-specific phospholipase C regulates activation of p42/44 mitogen-activated protein kinases in lipopolysaccharide- stimulated human alveolar macrophages. J Immunol 162:3005-3012. (Pubitemid 29309330)
26. Moreno-Garcia ME, Lopez-Bojorques LN, Zentella A, Humphries LA, Rawlings DJ, Santos-Argumedo L. 2005. CD38 signaling regulates B lymphocyte activation via a phospholipase C (PLC)-gamma 2-independent, protein kinase C, phosphatidylcholine-PLC, and phospholipase D-dependent signaling cascade. J Immunol 174:2687-2695. (Pubitemid 40279683)
27. Musacchio A, Hardwick KG. 2002. The spindle checkpoint: Structural insights into dynamic signalling. Nat Rev Mol Cell Biol 3:731-741.
28. Nakayama KI, Nakayama K. 2006. Ubiquitin ligases: Cell-cycle control and cancer. Nat Rev Cancer 6:369-381.
29. Nasmyth K. 2005. How do so few control so many? Cell 120:739-746.
30. Nishizuka Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614.
31. Nofer JR, Junker R, Seedorf U, Assmann G, Zidek W, Tepel M. 2000. D609-phosphatidylcholine-specific phospholipase C inhibitor attenuates thapsigargin-induced sodium influx in human lymphocytes. Cell Signal 12:289-296. (Pubitemid 30261543)
32. Pines J. 1997. Localization of cell cycle regulators by immunofluorescence. Methods Enzymol 283:99-112. (Pubitemid 27339775)
33. Plo I, Lautier D, Levade T, Sekouri H, Jaffrezou JP, Laurent G, Bettaieb A. 2000. Phosphatidylcholine-specific phospholipase C and phospholipase D are respectively implicated in mitogen-activated protein kinase and NF-κB activation in tumour-necrosis-factor-alpha-treated immature acute-myeloid- leukaemia cells. Biochem J 2:459-467. (Pubitemid 30825609)
34. Podo F, Ferretti A, Knijn A, Zhang P, Ramoni C, Barletta B, Pini C. 1996. Detection of phosphatidylcholine-specific phospholipase C in NIH-3T3 fibroblasts and their H-ras transformants: NMR and immunochemical studies. Anticancer Res 16:1399-1412. (Pubitemid 26257809)
35. Preuss I, Kaiser I, Gehring U. 2001. Molecular characterization of a phosphatidylcholine-hydrolyzing phospholipase C. Eur J Biochem 268:5081-5091.
36. Prinz S, Hwang ES, Visintin R, Amon A. 1998. The regulation of Cdc20 proteolysis reveals a role for APC components Cdc23 and Cdc27 during S phase and early mitosis. Curr Biol 8:750-760. (Pubitemid 28301161)
37. Ramoni C, Spadaro F, Menegon M, Podo F. 2001. Cellular localization and functional role of phosphatidylcholine-specific phospholipase C in NK cells. J Immunol 167:2642-2650. (Pubitemid 32768893)
38. Ramoni C, Spadaro F, Barletta B, Dupuis ML, Podo F. 2004. Phosphatidylcholine-specific phospholipase C in mitogen-stimulated fibroblasts. Exp Cell Res 299:370-382.
39. Reimann JD, Freed E, Hsu JY, Kramer ER, Peters JM, Jackson PK. 2001. Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex. Cell 105:645-655. (Pubitemid 32524117)
40. Rhee SG, Bae YS. 1997. Regulation of phosphoinositide-specific phospholipase C isozymes. J Biol Chem 272:15045-15048.
41. Schmidt A, Duncan PI, Rauh NR, Sauer G, Fry AM, Nigg EA, Mayer TU. 2005. Xenopus polo-like kinase Plx1 regulates XErp1, a novel inhibitor of APC/C activity. Genes Dev 19:502-513. (Pubitemid 40256281)
42. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M. 1992. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown. Cell 71:765-776.
43. Song MS, Song SJ, Ayad NG, Chang JS, Lee JH, Hong HK, Lee H, Choi N, Kim J, Kim H, Kim JW, Choi EJ, Kirschner MW, Lim DS. 2004. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol 6:129-137. (Pubitemid 38425712)
44. Spadaro F, Cecchetti S, Sanchez M, Podo F, Ramoni C. 2006. Expression and role of phosphatidylcholine-specific phospholipase C in human NK and T lymphocyte subsets. Eur J Immunol 36:3277-3287. (Pubitemid 44932729)
45. Thornton BR, Ng TM, Matyskiela ME, Carroll CW, Morgan DO, Toczyski DP. 2006. An architectural map of the anaphase-promoting complex. Genes Dev 20:449-460.
46. Tschaikowsky K, Schmidt J, Meisner M. 1998. Modulation of mouse endotoxin shock by inhibition of PC-PLC. J Pharmacol Exp Ther 285:800-804.
47. Wu XZ, Lu H. 1998. Correlation of calcium-independent phosphatidylcholine specific phospholipase C and gamma-GT in hepatoma cells. Acta Biochim Biophys Sin 30:104-106. (Pubitemid 128048207)
48. Wu XZ, Lu H, Zhou L, Huang Y, Chen H. 1997. Changes of phosphatidylcholine-specific phospholipase C in hepatocarcinogenesis and in the proliferation and differentiation of rat liver cancer cells. Cell Biol Int 21:375-381. (Pubitemid 27388916)
49. Yu H. 2002. Regulation of APC-Cdc20 by the spindle checkpoint. Curr Opin Cell Biol 14:706-714.
50. Yu H. 2007. Cdc20: A WD40 activator for a cell cycle degradation machine. Mol Cell 27:3-16. (Pubitemid 46991390)
51. Zamorano J, Rivas MD, Garcia-Trinidad A, Qu C, Keegan AD. 2003. Phosphatidylcholine-specific phospholipase C activity is necessary for the activation of STAT6. J Immunol 171:4203-4309. (Pubitemid 37238697)
52. Zhang F, Zhao G, Dong Z. 2001. Phosphatidylcholine-specific phospholipase C regulates activation of RAW264.7 macrophage-like cells by lipopeptide JBT3002. J Leukoc Biol 69:1060-1066. (Pubitemid 32577911)